KCNS1 (Kv9.1) is a voltage-gated potassium channel regulatory subunit that modulates delayed rectifier potassium channel activity by assembling into functional heterotetrameric complexes with KCNB1 (Kv2.1) and KCNB2 (Kv2.2) 1. The protein does not form functional channels independently but alters kinetics, expression levels, and half-inactivation potentials of partner channels 1, 2. KCNS1 is predominantly expressed in myelinated sensory neurons, including Aδ-fiber nociceptors and Aβ mechanoreceptors, as well as spinal dorsal horn and motoneurons 3. Functionally, KCNS1 regulates nociceptive excitability; mice lacking peripheral Kcns1 exhibit increased basal and neuropathic pain sensitivity with exaggerated mechanical and cold pain responses 3. Genetically, the KCNS1 rs734784 A>G variant marginally increases chr20 postsurgical pain risk (OR: 1.511) 4, and KCNS1 variation predicts pain sensitivity and chr20 pain risk in humans 5. Additionally, KCNS1 expression correlates with cortical developmental patterns and gene expression changes in psychiatric disorders during pubertal transition 6. These findings establish KCNS1 as a key regulator of neuronal excitability with significant implications for pain management and neurodevelopmental disorders.